Berlin, Berlin, Germany
I am a Finance and controlling expert with more than 26 years of experience in managing and advancing financial business processes in diverse cultural settings within the pharmaceutical industry. Strong expertise in financial performance management, business partnering, team leadership and development, as well as operational and strategic planning. Proven leadership capabilities in improving financial performance to support strategic decision-making and sustainably contribute to business success in a growth-oriented healthcare company.
• Leading financial reporting, analysis and business steering for global Radiology (~2 billion € sales) • Providing actionable financial guidance and decision support to the Radiology Leadership Team to steer the global financial performance for commercial operations, PS, R&D and global functions • Leading financial processes and resource allocation, providing strategic / financial perspective and supporting scenario planning for mid-to long term business development • Closely collaborating with and advising Brand Marketing and Supply Chain Management for profitability optimized product allocation • Successfully developed 3 direct reports into more complex positions outside Finance Radiology
• Led the financial steering and strategic/ operational performance management of the Mexican Pharma business with ~230 mio € sales (P&L planning & forecasting, commercial policy & strategies, resource and cash flow optimization, compliance adherence, audit support, business risk management) • Financial advising to the Pharma Country Head and local divisional management team, driving dedicated business analysis and decision support (i.e. business cases) • Coaching and development of 3 direct reports into trusted advisors and recognized business partners • Drove the optimization of value flows and ensured successful accomplishment of significant cost saving initiatives (2018-2021) thus significantly improving profitability
• Led Bayer Corporate Forecasting and Planning processes to enable proper financial steering of the Bayer Group • Successful re-engineering and timely implementation of Group FX simulation tool and concept in 2016 ensuring reliable Foreign Exchange simulations for respective analysis on Group level in alignment with Group Finance • Business Partnering to Group Board of Management and Group CFO by providing adequate analysis and regular reporting on Group´s business performance • Effective leadership and integration of 6 direct reports into new team in the course of NewBayer transition plus leadership of cross-divisional/-functional Reporting and Planning Board
• Global Process Owner for Bayer HealthCare (BHC) Reporting, chair of BHC Reporting Standards Board, ensuring substantial reporting governance in line with corporate requirements • Led entire global BHC Management reporting, annotation and analysis processes and regularly provided insights into BHC´s operational business performance to BHC Executive Committee and Bayer Group functions • Directed conceptual design, implementation and operation of global BHC Reporting Factory and Mgmt. Dashboard Family across the BHC organization in 2014 • Led the coordination, audit-proof documentation and reporting of financial / non-financial key input from BHC into Bayer´s external reporting (annual/quarter reports) • Leadership of 2 direct and 3 indirect reports as well as interdisciplinary leadership of cross-divisional/ cross-functional global teams (BHC Reporting Standards Board, BHC controller community in Region LATAM) • Directly interacted as business partner with BHC CFO and BHC Accounting; with BHC CEO on Investors Relations and Shareholder communication matters • Contributed to the M&A administration workstream in the course of the Merck Inc. Consumer business acquisition 2014
• Drove effective steering of global R&D Controlling processes for Actual, Forecast and Budget to enable financial R&D steering and performance management • Leading and developing 4 direct reports responsible for legal entity controlling and operation of the global R&D controlling and consolidation system PROFIT • Directed the management of all R&D financial and consolidation processes including interfaces to BHC Accounting and Group financial systems • Successfully coordinated and conducted the 2009 Global R&D Controlling conference in Leverkusen
• Steered the regional planning and forecasting processes regarding sales and consolidated contribution margin • Consulted 7 legal entities concerning operational and financial topics to ensure and improve consolidated financial results in line with regional targets • Implemented self-developed Controlling tools for effective financial consolidation and FX simulations ensuring proper business steering and planning for regional management team • Advised Regional Head and marketing managers as business partner providing sound financial business performance insights (e.g. product profitability analysis)